Matches in Wikidata for { <http://www.wikidata.org/entity/Q91935177> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q91935177 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91935177 description "bài báo khoa học" @default.
- Q91935177 description "scientific article published on 23 February 2019" @default.
- Q91935177 description "wetenschappelijk artikel" @default.
- Q91935177 description "наукова стаття, опублікована в лютому 2019" @default.
- Q91935177 name "Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists" @default.
- Q91935177 name "Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists" @default.
- Q91935177 type Item @default.
- Q91935177 label "Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists" @default.
- Q91935177 label "Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists" @default.
- Q91935177 prefLabel "Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists" @default.
- Q91935177 prefLabel "Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists" @default.
- Q91935177 P1433 Q91935177-E10BD4FA-B634-4EF9-96D7-B71946089C6A @default.
- Q91935177 P1476 Q91935177-0E766A84-A352-4DBC-A456-0CFD93DCA9AE @default.
- Q91935177 P2093 Q91935177-17FBC226-E6CF-43B2-BDD9-16D2B00BF5C2 @default.
- Q91935177 P2093 Q91935177-2E407D9F-8361-4090-94C2-2EE663554306 @default.
- Q91935177 P2093 Q91935177-42DF8C71-056F-4702-8AB1-D100F9F5CBFB @default.
- Q91935177 P304 Q91935177-A742D5FE-856C-43B4-AAA9-FFE75BE28870 @default.
- Q91935177 P31 Q91935177-25101BF8-2DC3-4E41-9412-D7B8221C62A5 @default.
- Q91935177 P356 Q91935177-C1A62F0D-C3EE-49C6-BD6F-FFA19ACC52DE @default.
- Q91935177 P478 Q91935177-5D572473-1AE7-4841-8530-9F868ABCEF09 @default.
- Q91935177 P577 Q91935177-543E6BCA-0EA0-4A33-8AD3-0D144FFDEC22 @default.
- Q91935177 P698 Q91935177-D937F5EA-56D4-439C-8ABB-A46A7CF47EFD @default.
- Q91935177 P921 Q91935177-333A5C42-5F97-44B7-9B48-089B952F7DDC @default.
- Q91935177 P356 J.TAAP.2019.02.013 @default.
- Q91935177 P698 30807757 @default.
- Q91935177 P1433 Q2446974 @default.
- Q91935177 P1476 "Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists" @default.
- Q91935177 P2093 "Joseph E Henriquez" @default.
- Q91935177 P2093 "Norbert E Kaminski" @default.
- Q91935177 P2093 "Robert B Crawford" @default.
- Q91935177 P304 "82-89" @default.
- Q91935177 P31 Q13442814 @default.
- Q91935177 P356 "10.1016/J.TAAP.2019.02.013" @default.
- Q91935177 P478 "369" @default.
- Q91935177 P577 "2019-02-23T00:00:00Z" @default.
- Q91935177 P698 "30807757" @default.
- Q91935177 P921 Q506253 @default.